Minimally invasive diagnostic techniques in evaluating patients with b
reast disease have been increasingly utilized and accepted by physicia
ns and patients over recent years. The incorporation of stereotactic c
ore needle biopsy and ultrasound-guided core needle biopsy into the of
fice practice of evaluating patients with breast disease by our surgic
al faculty has been met favorably. These procedures are readily learne
d by surgeons. The judicious use of these procedures is evidenced by t
he malignancy rate of core biopsies of 16 per cent, identical to the h
istorical rate for needle localization assisted excisional biopsy at o
ur institution. Core breast biopsy expedites definitive diagnosis and
optimizes patient convenience. Reimbursement is highly variable, and a
ctive physician participation in negotiating with payers to insure tha
t costs are met is essential.